IE38221B1 - Novel tetracyclic pyramidines - Google Patents

Novel tetracyclic pyramidines

Info

Publication number
IE38221B1
IE38221B1 IE1587/73A IE158773A IE38221B1 IE 38221 B1 IE38221 B1 IE 38221B1 IE 1587/73 A IE1587/73 A IE 1587/73A IE 158773 A IE158773 A IE 158773A IE 38221 B1 IE38221 B1 IE 38221B1
Authority
IE
Ireland
Prior art keywords
pyramidines
novel tetracyclic
tetracyclic
novel
us3892695a
Prior art date
Application number
IE1587/73A
Other versions
IE38221L (en
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of IE38221L publication Critical patent/IE38221L/en
Publication of IE38221B1 publication Critical patent/IE38221B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Compounds of the formula: [US3892695A]
IE1587/73A 1972-09-23 1973-09-06 Novel tetracyclic pyramidines IE38221B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7212915,A NL176458C (en) 1972-09-23 1972-09-23 PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING ACTIVE SUBSTANCES SUITABLE.

Publications (2)

Publication Number Publication Date
IE38221L IE38221L (en) 1974-03-23
IE38221B1 true IE38221B1 (en) 1978-01-18

Family

ID=19816997

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1587/73A IE38221B1 (en) 1972-09-23 1973-09-06 Novel tetracyclic pyramidines

Country Status (18)

Country Link
US (1) US3892695A (en)
JP (1) JPS5912678B2 (en)
AR (1) AR203090A1 (en)
AU (1) AU472312B2 (en)
BE (1) BE805178A (en)
CA (1) CA1019733A (en)
CH (1) CH592094A5 (en)
DE (1) DE2347727C2 (en)
DK (1) DK140668B (en)
ES (1) ES418996A1 (en)
FI (1) FI54311C (en)
FR (1) FR2199996B1 (en)
GB (1) GB1445765A (en)
HU (1) HU167206B (en)
IE (1) IE38221B1 (en)
NL (1) NL176458C (en)
SE (1) SE407686B (en)
ZA (1) ZA737131B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217452A (en) * 1974-02-09 1980-08-12 Akzona Incorporated Synthesis for the preparation of tetracyclic compounds
NL179906C (en) * 1974-02-09 1986-12-01 Akzo Nv PROCESS FOR PREPARING 1,2,3,4,10,14B-HEXAHYDRODIBENZO (C, F) PYRAZINO (1,2-A) AZEPINE DERIVATIVES.
NL7414038A (en) * 1974-10-28 1976-05-03 Akzo Nv NEW TETRACYCLIC PYRROLIDINO DERIVATIVES.
GB1472382A (en) * 1975-01-16 1977-05-04 Wyeth John & Brother Ltd Dibenzopyrimidoazepines
NL7610942A (en) * 1976-10-02 1978-04-04 Akzo Nv PROCESS FOR PREPARING 1,4-DIAZEPINE DERIVATIVES.
NL7809726A (en) * 1978-09-26 1980-03-28 Akzo Nv NEW TETRACYCLIC CONNECTIONS.
HU195491B (en) * 1985-12-20 1988-05-30 Egyt Gyogyszervegyeszeti Gyar Process for production of optically active 2-chlor-12-/3-/dimethil-amin/-2-methil-prophil/-12h-dibenzol /d,g/ /1,3,6/-diaxazocine and medical compositions containing such compounds
CH678623A5 (en) * 1989-05-17 1991-10-15 Sochinaz Societe Chimique De V Prepn. of di:benzo pyrazino azepine(s)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154511B (en) * 1967-07-07 1977-09-15 Organon Nv PROCESS FOR PREPARING PIPERAZINE DERIVATIVES, PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING SUCH A COMPOUND AND MOLDS PREPARED ACCORDING TO THIS PROCEDURE.
US3470181A (en) * 1967-10-23 1969-09-30 American Home Prod Fused 2-pyrimidinepropionic acid compounds,related compounds,and the process for their preparation

Also Published As

Publication number Publication date
BE805178A (en) 1974-03-21
CH592094A5 (en) 1977-10-14
NL7212915A (en) 1974-03-26
DE2347727A1 (en) 1974-04-04
DE2347727C2 (en) 1986-12-11
ZA737131B (en) 1974-08-28
NL176458B (en) 1984-11-16
FR2199996A1 (en) 1974-04-19
FI54311C (en) 1978-11-10
FR2199996B1 (en) 1977-09-09
JPS4985098A (en) 1974-08-15
AR203090A1 (en) 1975-08-14
AU472312B2 (en) 1976-05-20
HU167206B (en) 1975-09-27
NL176458C (en) 1985-04-16
SE407686B (en) 1979-04-09
JPS5912678B2 (en) 1984-03-24
GB1445765A (en) 1976-08-11
DK140668C (en) 1980-03-24
US3892695A (en) 1975-07-01
DK140668B (en) 1979-10-22
ES418996A1 (en) 1976-07-01
AU6019773A (en) 1975-03-13
FI54311B (en) 1978-07-31
IE38221L (en) 1974-03-23
CA1019733A (en) 1977-10-25

Similar Documents

Publication Publication Date Title
IE37056L (en) PYRROLO [3,4-b] PYRAZINES
IE34720B1 (en) Xanthone derivatives
IE36725B1 (en) Tetrazole derivatives
IE36878B1 (en) Isoindoline derivatives
IE34201L (en) Phenoxyhydroxypropylamines
CA1014446A (en) Perfluoralkylphosphorus compounds as foam-dampening agents
IE40141L (en) Benzimidazole-2-carbamate derivatives
IE37688L (en) O-(substituted) oxime derivatives of hydroxyphthalaldehydic¹acids
IE40217L (en) Preparation of chlorinated phenyl-hydroxylamines.
IE38221B1 (en) Novel tetracyclic pyramidines
IE37322L (en) Imidazodibenzoazepines
IE37220L (en) Pyrrolopyridine derivatives
IE39229L (en) Amino-substituted tetracyclic compounds
IE38615L (en) Penicillin compounds
IE36207L (en) Lumilyserol derivatives
IE38561B1 (en) 1,4-dithiino 2,3-cpyrrole derivatives
IE38686L (en) 3-hydrazonomethyl rifamycin
IE39233L (en) Pyridino-dibenzo-azepine,-diazepine, -oxazepine and¹-thiazepine derivatives
IE40172L (en) Acylamino - phenyl - acetamidine anthelmintics
CA1008457A (en) Preparation of 2-pyrrolidinone
IE38190L (en) Diaza-oxa-bicyclodecane derivatives
ES411710A1 (en) Nitroimidazolyl-triazolo-pyridazine compounds
CA906494A (en) Production of n-aryl-cyclicimide compounds
IE39813B1 (en) 7h-indolizino 5,6,7ij)isoquinoline derivatives
AU484459B2 (en) Use of perfluoralkylphosphorus compounds as foam-dampening agents